BACKGROUND: Heart failure (HF) is associated with excessive extracellular matrix (ECM) deposition and abnormal ECM degradation leading to cardiac fibrosis. Connective tissue growth factor (CTGF) modulates ECM production during inflammatory tissue injury, but available data on CTGF gene expression in failing human heart and its response to mechanical unloading are limited. METHODS AND RESULTS: Left ventricle (LV) tissue from patients undergoing cardiac transplantation for ischemic (ICM; n = 20) and dilated (DCM; n = 20) cardiomyopathies and from nonfailing (NF; n = 20) donor hearts were examined. Paired samples (n = 15) from patients undergoing LV assist device (LVAD) implantation as "bridge to transplant" (34-1,145 days) also were analyzed. There was more interstitial fibrosis in both ICM and DCM compared with NF hearts. Hydroxyproline concentration was also significantly increased in DCM compared with NF samples. The expression of CTGF, transforming growth factor (TGF) β1, collagen (COL) 1-α1, COL3-α1, matrix metalloproteinase (MMP) 2, and MMP9 mRNA in ICM and DCM were also significantly elevated compared with NF samples. Although TGF-β1, CTGF, COL1-α1, and COL3-α1 mRNA levels were reduced by unloading, there was only a modest reduction in tissue fibrosis and no difference in protein-bound hydroxyproline concentration between pre- and post-LVAD tissue samples. The persistent fibrosis may be related to a concomitant reduction in MMP9 mRNA and protein levels following unloading. CONCLUSIONS: CTGF may be a key regulator of fibrosis during maladaptive remodeling and progression to HF. Although mechanical unloading normalizes most genotypic and functional abnormalities, its effect on ECM remodeling during HF is incomplete.
BACKGROUND:Heart failure (HF) is associated with excessive extracellular matrix (ECM) deposition and abnormal ECM degradation leading to cardiac fibrosis. Connective tissue growth factor (CTGF) modulates ECM production during inflammatory tissue injury, but available data on CTGF gene expression in failing human heart and its response to mechanical unloading are limited. METHODS AND RESULTS: Left ventricle (LV) tissue from patients undergoing cardiac transplantation for ischemic (ICM; n = 20) and dilated (DCM; n = 20) cardiomyopathies and from nonfailing (NF; n = 20) donor hearts were examined. Paired samples (n = 15) from patients undergoing LV assist device (LVAD) implantation as "bridge to transplant" (34-1,145 days) also were analyzed. There was more interstitial fibrosis in both ICM and DCM compared with NF hearts. Hydroxyproline concentration was also significantly increased in DCM compared with NF samples. The expression of CTGF, transforming growth factor (TGF) β1, collagen (COL) 1-α1, COL3-α1, matrix metalloproteinase (MMP) 2, and MMP9 mRNA in ICM and DCM were also significantly elevated compared with NF samples. Although TGF-β1, CTGF, COL1-α1, and COL3-α1 mRNA levels were reduced by unloading, there was only a modest reduction in tissue fibrosis and no difference in protein-bound hydroxyproline concentration between pre- and post-LVAD tissue samples. The persistent fibrosis may be related to a concomitant reduction in MMP9 mRNA and protein levels following unloading. CONCLUSIONS:CTGF may be a key regulator of fibrosis during maladaptive remodeling and progression to HF. Although mechanical unloading normalizes most genotypic and functional abnormalities, its effect on ECM remodeling during HF is incomplete.
Authors: Annette H Bruggink; Matthijs F M van Oosterhout; Nicolaas de Jonge; Bas Ivangh; Joyce van Kuik; Ron H A M Voorbij; Jack P M Cleutjens; Frits H J Gmelig-Meyling; Roel A de Weger Journal: J Heart Lung Transplant Date: 2006-08-02 Impact factor: 10.247
Authors: Carol G Au; Tanya L Butler; Megan C Sherwood; Jonathan R Egan; Kathryn N North; David S Winlaw Journal: Int J Exp Pathol Date: 2010-12-01 Impact factor: 1.925
Authors: Y Y Li; Y Q Feng; T Kadokami; C F McTiernan; R Draviam; S C Watkins; A M Feldman Journal: Proc Natl Acad Sci U S A Date: 2000-11-07 Impact factor: 11.205
Authors: Federica Accornero; Jop H van Berlo; Robert N Correll; John W Elrod; Michelle A Sargent; Allen York; Joseph E Rabinowitz; Andrew Leask; Jeffery D Molkentin Journal: Mol Cell Biol Date: 2015-04-13 Impact factor: 4.272
Authors: Brian L Stauffer; Karen Dockstader; Gloria Russell; Jamie Hijmans; Lisa Walker; Mackenzie Cecil; Kimberly Demos-Davies; Allen Medway; Timothy A McKinsey; Carmen C Sucharov Journal: Biochem Biophys Res Commun Date: 2015-04-29 Impact factor: 3.575
Authors: Joshua G Travers; Fadia A Kamal; Jeffrey Robbins; Katherine E Yutzey; Burns C Blaxall Journal: Circ Res Date: 2016-03-18 Impact factor: 17.367
Authors: Yevgeniya E Koshman; Miensheng Chu; Taehoon Kim; Olivia Kalmanson; Mariam Farjah; Mohit Kumar; William Lewis; David L Geenen; Pieter de Tombe; Paul H Goldspink; R John Solaro; Allen M Samarel Journal: J Mol Cell Cardiol Date: 2014-04-05 Impact factor: 5.000
Authors: Maria Chatzifrangkeskou; Caroline Le Dour; Wei Wu; John P Morrow; Leroy C Joseph; Maud Beuvin; Fusako Sera; Shunichi Homma; Nicolas Vignier; Nathalie Mougenot; Gisèle Bonne; Kenneth E Lipson; Howard J Worman; Antoine Muchir Journal: Hum Mol Genet Date: 2016-04-30 Impact factor: 6.150
Authors: Guanghong Jia; Javad Habibi; Vincent G DeMarco; Luis A Martinez-Lemus; Lixin Ma; Adam T Whaley-Connell; Annayya R Aroor; Timothy L Domeier; Yi Zhu; Gerald A Meininger; Katelee Barrett Mueller; Iris Z Jaffe; James R Sowers Journal: Hypertension Date: 2015-10-05 Impact factor: 10.190
Authors: Miensheng Chu; Stefanie Mares Novak; Cathleen Cover; Anne A Wang; Ikeotunye Royal Chinyere; Elizabeth B Juneman; Daniela C Zarnescu; Pak Kin Wong; Carol C Gregorio Journal: Circulation Date: 2017-11-03 Impact factor: 29.690
Authors: Yevgeniya E Koshman; Mark D Sternlicht; Taehoon Kim; Christopher P O'Hara; Christopher A Koczor; William Lewis; Todd W Seeley; Kenneth E Lipson; Allen M Samarel Journal: J Mol Cell Cardiol Date: 2015-11-05 Impact factor: 5.000